LPL and Hyperglycemia: Intravenous insulin is a non-invasive treatment by increasing activation of lipoprotein lipase (LPL) to accelerate chylomicron breakdown, and would be recommended in patients with concomitant hyperglycemia, especially with metabolic decompensation such as ketoacidosis12,13.